Validation of the French Adaptation of the RAADS-R Scale : Scale of Asperger Syndrome Diagnosis

NCT02826148 | Completed

• 1 other identifier: 8747
• Study Type: interventional
• Target: 324
• Locations: 0 countries
• Sites: N/A

Brief Summary

The diagnosis of developmental disorders in adults is still difficult. Indeed, in France, there is not questionnaires to easily and accurately diagnose this disorder. Several diagnostic scales were developed in English. Among them, RAADS-R scale, which is a clinical tool that aims to better identify autism spectrum disorders including mild forms in adult people and help to diagnose of high-functioning autism . The objective of this study is to perform a complete validation of this scale in the french version.

Conditions

Autism Spectrum Disorder

Outcome Measures

Primary Outcomes (1)

• score at the RAADS-R scale

  The scale contains 80 items including 64 questions describe specific symptoms of autism spectrum disorders and 16 questions describe non-symptomatic behaviors

  15 days

Study Arms (1)

Patients with autism disorder

OTHER

The RAADS-R scale is a self-administered questionnaire completed by the patient himself assisted by a clinician

Other: RAADS-R scale

Interventions

RAADS-R scale OTHER

This scale is a self-administered questionnaire completed by the person himself assisted by a clinician

Patients with autism disorder

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Non-specific criteria
• Collection of the informed consent (patient or legal representant)
• Affiliation or recipient with the mode of social security
• Current reading skills evaluated by completion of the fact sheet attached to the scale
• Age limits to \> 18 years and \< 75 years
• Specific criteria
• Group of adult subjects with autism
• Diagnosis of autism or Asperger syndrome established within the framework of a multidisciplinary evaluation (ADOS module 4 and/or ADI) using specific international classification criteria of rare diseases (CIM 10, DSM IV-R) (F84.0 et F84.5).
• Intellectual efficiency estimated by means of a psychometric tool standardized (WAIS, WASI) greater than or equal to 85
• Subjects not denying their symptoms
• Group of adult subjects with other psychiatric
• Diagnosis of an other psychiatric trouble established according to the specific international classification criteria of mental diseases (CIM 10, DSM IV).
• absence of pervasive developmental disorder diagnosis
• Subjects not denying their symptoms
• Group of adult subjects not carriers of development and/or psychiatric disorders

You may not qualify if:

• Women pregnant and Breast-feeding
• Persons deprived of freedom by court order
• Specific criteria
• Group of adult subjects with autism
• Refusal of participation
• absence of autism or Asperger syndrome diagnosis
• Group of adult subjects with other psychiatric
• Refusal of participation
• Pervasive developmental disorder diagnosis
• Group of adult subjects not carriers of development and/or psychiatric disorders
• Refusal of participation
• Diagnosis of cognitive development or psychomotor disorder, diagnosis of retard mental and/or psychiatric disorder.

Sponsors & Collaborators

• University Hospital, Montpellier: lead
• Fondation Orange: collaborator

MeSH Terms

Conditions

Autism Spectrum Disorder

Condition Hierarchy (Ancestors)

Child Development Disorders, Pervasive; Neurodevelopmental Disorders; Mental Disorders

Study Officials

• Amaria BAGHDADLI, MD-PhD

  University Hospital, Montpellier

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: DIAGNOSTIC
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 5, 2016
• First Posted: July 7, 2016
• Study Start: December 1, 2011
• Primary Completion: December 1, 2015
• Study Completion: December 1, 2015
• Last Updated: July 7, 2016

Record last verified: 2016-03

Data Sharing

• IPD Sharing: Will not share